BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Interim Response and Safety Analyses Support Continuation of Allos Therapeutics, Inc.'s Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma

  September 24, 2007

   · 

  7 min read
• Business

  Ceapro Inc. Boosting Investment in High Technology at New Facility, Announces Improved Refinancing

  September 24, 2007

   · 

  1 min read
• Drug Development

  Sonus Pharmaceuticals, Inc. to Hold Conference Call to Discuss Results from Pivotal Phase 3 Trial of TOCOSOL(R) Paclitaxel

  September 24, 2007

   · 

  1 min read
• Business

  Richard Love Joins Board of Directors of Cell Therapeutics, Inc.

  September 24, 2007

   · 

  3 min read
• Biotech Beach

  Sequenom Inc. to Webcast Analyst and Investor Briefing Presentation on September 24

  September 24, 2007

   · 

  1 min read
• Biotech Bay

  Bionovo, Inc. Announces Proposed Public Offering of Common Stock

  September 24, 2007

   · 

  3 min read
• BioMidwest

  Advanced Life Sciences Holdings, Inc. Joins NASDAQ Capital Market

  September 24, 2007

   · 

  1 min read
• Pharm Country

  Lixte Biotechnology Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT

  September 24, 2007

   · 

  4 min read
• Daiichi Sankyo, Inc. Release: New Data Show Olmesartan, An Angiotensin Receptor Blocker (ARB) Has Significant Anti-atherosclerotic And Vascular Protective

  September 24, 2007

   · 

  1 min read
• Business

  Dyadic International, Inc. (Jobs) Announces President and CEO to Leave

  September 24, 2007

   · 

  4 min read